Free Trial
OTCMKTS:PBIO

Pressure BioSciences (PBIO) Stock Price, News & Analysis

Pressure BioSciences logo
$0.0005 0.00 (0.00%)
As of 10/10/2025 01:29 PM Eastern

About Pressure BioSciences Stock (OTCMKTS:PBIO)

Advanced

Key Stats

Today's Range
$0.0005
$0.0005
50-Day Range
N/A
52-Week Range
$0.00
$0.11
Volume
21,000 shs
Average Volume
901 shs
Market Capitalization
$21.49 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pressure BioSciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

PBIO MarketRank™: 

Pressure BioSciences scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pressure BioSciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pressure BioSciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pressure BioSciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Pressure BioSciences have been sold short.
  • Short Interest Ratio / Days to Cover

    Pressure BioSciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Pressure BioSciences does not currently pay a dividend.

  • Dividend Growth

    Pressure BioSciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Pressure BioSciences have been sold short.
  • Short Interest Ratio / Days to Cover

    Pressure BioSciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Search Interest

    1 people have searched for PBIO on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Pressure BioSciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pressure BioSciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.80% of the stock of Pressure BioSciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.02% of the stock of Pressure BioSciences is held by institutions.

  • Read more about Pressure BioSciences' insider trading history.
Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBIO Stock News Headlines

URGENT: The Market's 3 Red Flags Are Flashing
Here’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash before 2025 ends.tc pixel
The big blood pressure experiment
See More Headlines

PBIO Stock Analysis - Frequently Asked Questions

Pressure BioSciences' stock was trading at $0.0035 at the beginning of the year. Since then, PBIO stock has decreased by 85.7% and is now trading at $0.0005.

Pressure BioSciences Inc. (OTCMKTS:PBIO) released its quarterly earnings results on Friday, February, 7th. The company reported ($0.15) earnings per share (EPS) for the quarter.

Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pressure BioSciences investors own include Hydrofarm Holdings Group (HYFM), Advanced Micro Devices (AMD), Monaker Group (MKGI), Meta Materials (MMAT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP) and Novavax (NVAX).

Company Calendar

Last Earnings
2/07/2025
Today
10/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Measuring And Control Equipment
Current Symbol
OTCMKTS:PBIO
CIK
830656
Employees
10
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.98 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.29) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
42,970,000
Free Float
38,327,000
Market Cap
$21.49 thousand
Optionable
Not Optionable
Beta
-0.22

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:PBIO) was last updated on 10/12/2025 by MarketBeat.com Staff
From Our Partners